|
English
|
正體中文
|
简体中文
|
2828323
|
|
???header.visitor??? :
32275747
???header.onlineuser??? :
974
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"foo s"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立臺灣大學 |
2016 |
First-line ribociclib plus letrozole in postmenopausal Asian women with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): A subgroup analysis from MONALEESA-2
|
Yap, Y. S.; Tseng, L-M.; Blackwell, K. L.; Cameron, D.; Foo, S.; Sriuranpong, V.; Huang, C-S.; Chao, T-Y.; Kim, T-Y.; Chen, S-C.; Jung, K. H.; Lee, K. S.; Sohn, J-H.; Kim, J. H.; Hou, M-F.; Han, Y.; Souami, F.; Dhuria, S.; Miller, M.; Verma, S.; 黃俊升 |
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
